Coya Therapeutics (COYA) Retained Earnings (2022 - 2025)
Coya Therapeutics (COYA) has disclosed Retained Earnings for 4 consecutive years, with -$62.0 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 52.11% to -$62.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$62.0 million through Dec 2025, down 52.11% year-over-year, with the annual reading at -$62.0 million for FY2025, 52.11% down from the prior year.
- Retained Earnings hit -$62.0 million in Q4 2025 for Coya Therapeutics, down from -$56.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$17.9 million in Q4 2022 to a low of -$62.0 million in Q4 2025.
- Historically, Retained Earnings has averaged -$36.8 million across 4 years, with a median of -$33.8 million in 2024.
- Biggest five-year swings in Retained Earnings: plummeted 39.45% in 2024 and later plummeted 60.17% in 2025.
- Year by year, Retained Earnings stood at -$17.9 million in 2022, then plummeted by 44.7% to -$25.9 million in 2023, then tumbled by 57.55% to -$40.7 million in 2024, then tumbled by 52.11% to -$62.0 million in 2025.
- Business Quant data shows Retained Earnings for COYA at -$62.0 million in Q4 2025, -$56.3 million in Q3 2025, and -$54.1 million in Q2 2025.